Does VINDESINE Cause Second primary malignancy? 26 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Second primary malignancy have been filed in association with VINDESINE. This represents 1.3% of all adverse event reports for VINDESINE.
26
Reports of Second primary malignancy with VINDESINE
1.3%
of all VINDESINE reports
12
Deaths
4
Hospitalizations
How Dangerous Is Second primary malignancy From VINDESINE?
Of the 26 reports, 12 (46.2%) resulted in death, 4 (15.4%) required hospitalization, and 3 (11.5%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VINDESINE. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does VINDESINE Cause?
Myelosuppression (429)
Off label use (148)
Bone marrow failure (141)
Pyrexia (138)
Anaemia (137)
Leukopenia (127)
White blood cell count decreased (124)
Febrile neutropenia (115)
Pneumonia (110)
Thrombocytopenia (93)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which VINDESINE Alternatives Have Lower Second primary malignancy Risk?
VINDESINE vs VINORELBINE
VINDESINE vs VINORELBINE\VINORELBINE
VINDESINE vs VIREAD
VINDESINE vs VISIPAQUE
VINDESINE vs VISMODEGIB